1.04
price up icon19.54%   0.17
after-market Handel nachbörslich: 1.04
loading
Schlusskurs vom Vortag:
$0.87
Offen:
$1
24-Stunden-Volumen:
1,876
Relative Volume:
0.88
Marktkapitalisierung:
$N/A
Einnahmen:
$52.16M
Nettoeinkommen (Verlust:
$-48.60M
KGV:
-0.2407
EPS:
-4.32
Netto-Cashflow:
$-77.48M
1W Leistung:
+19.54%
1M Leistung:
+19.54%
6M Leistung:
+19.13%
1J Leistung:
-82.58%
1-Tages-Spanne:
Value
$1.00
$1.05
1-Wochen-Bereich:
Value
$1.00
$1.05
52-Wochen-Spanne:
Value
$0.86
$1.05

Hookipa Pharma Inc Stock (HOOK) Company Profile

Name
Firmenname
Hookipa Pharma Inc
Name
Telefon
-
Name
Adresse
-
Name
Mitarbeiter
0
Name
Twitter
Name
Nächster Verdiensttermin
Name
Neueste SEC-Einreichungen
Name
HOOK's Discussions on Twitter

Compare HOOK vs VRTX, REGN, ARGX, ALNY, ONC

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
HOOK
Hookipa Pharma Inc
1.04 0 52.16M -48.60M -77.48M -4.32
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
486.03 126.21B 12.07B 3.95B 3.19B 15.33
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
790.81 82.64B 14.34B 4.50B 3.77B 41.56
Biotechnology icon
ARGX
Argen X Se Adr
756.76 47.46B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
325.07 44.15B 3.71B 313.75M 465.38M 2.2571
Biotechnology icon
ONC
Beone Medicines Ltd Adr
314.36 35.08B 4.98B 69.60M 525.67M 0.5198

Hookipa Pharma Inc Stock (HOOK) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2024-12-20 Herabstufung RBC Capital Mkts Outperform → Sector Perform
2024-11-15 Bestätigt RBC Capital Mkts Outperform
2022-12-02 Herabstufung BofA Securities Buy → Underperform
2021-11-12 Herabstufung Morgan Stanley Overweight → Equal-Weight
2021-04-08 Eingeleitet Morgan Stanley Overweight
2020-11-03 Eingeleitet Truist Buy
2020-10-26 Eingeleitet JMP Securities Mkt Outperform
2020-10-19 Fortgesetzt H.C. Wainwright Buy
2019-09-27 Eingeleitet H.C. Wainwright Buy
2019-05-13 Eingeleitet BofA/Merrill Buy
2019-05-13 Eingeleitet RBC Capital Mkts Outperform
Alle ansehen

Hookipa Pharma Inc Aktie (HOOK) Neueste Nachrichten

pulisher
Mar 01, 2026

HOOKIPA Pharma Stock: What Latest Pipeline Moves Mean for U.S. Investors - AD HOC NEWS

Mar 01, 2026
pulisher
Feb 26, 2026

HOOKIPA Pharma (HOOK) Expected to Announce Earnings on Friday - Defense World

Feb 26, 2026
pulisher
Feb 24, 2026

Risk Check: Will HOOKIPA Pharma Inc benefit from government policy2025 EndofYear Setup & Entry Point Confirmation Signals - baoquankhu1.vn

Feb 24, 2026
pulisher
Feb 20, 2026

Why HOOKIPA Pharma Inc. stock remains on buy lists2025 Growth vs Value & AI Powered Market Entry Ideas - mfd.ru

Feb 20, 2026
pulisher
Feb 17, 2026

How does HOOKIPA Pharma Inc. compare to its peersWeekly Trade Summary & Real-Time Stock Price Movement Reports - mfd.ru

Feb 17, 2026
pulisher
Feb 15, 2026

Aug Outlook: What is the dividend yield of HOOKIPA Pharma Inc2025 Risk Factors & AI Forecasted Entry/Exit Points - baoquankhu1.vn

Feb 15, 2026
pulisher
Feb 12, 2026

Published on: 2026-02-12 12:26:37 - mfd.ru

Feb 12, 2026
pulisher
Feb 09, 2026

Why retail investors pile into HOOKIPA Pharma Inc. stockIPO Watch & Capital Efficiency Focused Strategies - mfd.ru

Feb 09, 2026
pulisher
Feb 04, 2026

HOOKIPA Pharma T0 Sell Oncology Assets HB-200 And HB-700 To NeoTrail Therapeutics - Nasdaq

Feb 04, 2026
pulisher
Feb 03, 2026

HOOKIPA Pharma (HOOK) Divests Key Immuno-Oncology Assets - GuruFocus

Feb 03, 2026
pulisher
Feb 03, 2026

HOOKIPA Pharma Announces Sale of Oncology Assets to NeoTrail Therapeutics - markets.businessinsider.com

Feb 03, 2026
pulisher
Feb 03, 2026

HOOKIPA Pharma Sells Oncology Assets To NeoTrail Therapeutics - citybiz

Feb 03, 2026
pulisher
Feb 03, 2026

HOOKIPA Pharma Inc. Sells Immuno-Oncology Assets HB-200 and HB-700 to NeoTrail Therapeutics - Quiver Quantitative

Feb 03, 2026
pulisher
Feb 03, 2026

Hookipa Pharma Announces Sale Of Oncology Assets To Neotrail Therapeutics - TradingView

Feb 03, 2026
pulisher
Jan 24, 2026

Dip Buying: How does HOOKIPA Pharma Inc compare to its peersWeekly Earnings Recap & Growth Oriented Trading Recommendations - baoquankhu1.vn

Jan 24, 2026
pulisher
Jan 17, 2026

Stock Analysis: Can HOOKIPA Pharma Inc deliver consistent EPS growthJuly 2025 Analyst Calls & Capital Efficiency Focused Ideas - baoquankhu1.vn

Jan 17, 2026
pulisher
Jan 12, 2026

Growth Value: Will HOOKIPA Pharma Inc benefit from government policyTrade Volume Summary & Daily Oversold Bounce Ideas - baoquankhu1.vn

Jan 12, 2026
pulisher
Jan 10, 2026

Will HOOKIPA Pharma Inc. stock benefit from commodity pricesMarket Performance Summary & Free Accurate Trade Setup Notifications - ulpravda.ru

Jan 10, 2026
pulisher
Jan 10, 2026

Will HOOKIPA Pharma Inc. stock outperform growth indexesQuarterly Risk Review & High Conviction Buy Zone Alerts - Улправда

Jan 10, 2026
pulisher
Jan 08, 2026

How risky is HOOKIPA Pharma Inc. stock nowQuarterly Profit Report & Long-Term Growth Portfolio Plans - Улправда

Jan 08, 2026
pulisher
Jan 08, 2026

Why HOOKIPA Pharma Inc. stock remains resilientTrade Entry Report & AI Optimized Trade Strategies - Улправда

Jan 08, 2026
pulisher
Jan 08, 2026

Is CEL SCI Corporation stock a contrarian buyPortfolio Performance Summary & Risk Adjusted Buy and Sell Alerts - ulpravda.ru

Jan 08, 2026
pulisher
Dec 20, 2025

Update Report: Will HOOKIPA Pharma Inc. stock outperform growth indexes2025 Momentum Check & Fast Momentum Entry Tips - Улправда

Dec 20, 2025
pulisher
Dec 20, 2025

Will HOOKIPA Pharma Inc. stock maintain momentum in 2025Weekly Loss Report & Fast Momentum Stock Entry Tips - Улправда

Dec 20, 2025
pulisher
Dec 18, 2025

Is HOOKIPA Pharma Inc. stock near bottom after declineJuly 2025 Rallies & Weekly Market Pulse Alerts - Улправда

Dec 18, 2025
pulisher
Dec 14, 2025

Aug Sentiment: Why HOOKIPA Pharma Inc stock remains resilientJuly 2025 PostEarnings & Growth Focused Stock Reports - moha.gov.vn

Dec 14, 2025
pulisher
Dec 03, 2025

Is HOOKIPA Pharma Inc. stock trading at a premium valuationInsider Buying & Reliable Breakout Forecasts - Newser

Dec 03, 2025
pulisher
Dec 03, 2025

Why HOOKIPA Pharma Inc. stock is trending among retail tradersPortfolio Update Summary & AI Powered Trade Plan Recommendations - Newser

Dec 03, 2025
pulisher
Nov 26, 2025

Gilead to buy certain Hookipa Pharma assets for up to $10M - MSN

Nov 26, 2025
pulisher
Nov 22, 2025

HOOKIPA Pharma Inc Stock Analysis and ForecastMarket Volatility Update & Hedge Fund-Style Analysis Now Free - earlytimes.in

Nov 22, 2025
pulisher
Nov 21, 2025

What drives HOOKIPA Pharma Inc stock priceVolume Weighted Average Price & Affordable Trading Strategies - earlytimes.in

Nov 21, 2025
pulisher
Nov 21, 2025

Is HOOKIPA Pharma Inc. stock supported by strong cash flowsEarnings Beat & Target Return Focused Stock Picks - newser.com

Nov 21, 2025
pulisher
Nov 20, 2025

Can HOOKIPA Pharma Inc. stock reach $100 price targetTrade Volume Report & Verified Entry Point Signals - newser.com

Nov 20, 2025
pulisher
Nov 19, 2025

Why HOOKIPA Pharma Inc. stock appeals to dividend seekersMarket Volume Report & Safe Swing Trade Setups - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Will HOOKIPA Pharma Inc. stock deliver strong dividend growth2025 Technical Overview & Expert Verified Stock Movement Alerts - newser.com

Nov 19, 2025
pulisher
Nov 18, 2025

Forecasting HOOKIPA Pharma Inc. price range with options dataWeekly Gains Report & Accurate Entry/Exit Alerts - newser.com

Nov 18, 2025
pulisher
Nov 16, 2025

How HOOKIPA Pharma Inc. stock reacts to oil pricesWeekly Gains Report & Real-Time Market Sentiment Alerts - newser.com

Nov 16, 2025
pulisher
Nov 16, 2025

Is HOOKIPA Pharma Inc. stock a good choice for value investorsLong Setup & Community Trade Idea Sharing - newser.com

Nov 16, 2025
pulisher
Nov 16, 2025

Evaluating HOOKIPA Pharma Inc. with trendline analysisQuarterly Trade Summary & Step-by-Step Trade Execution Guides - newser.com

Nov 16, 2025
pulisher
Nov 15, 2025

Why HOOKIPA Pharma Inc. stock is favored by pension funds2025 Key Highlights & Community Verified Trade Alerts - newser.com

Nov 15, 2025

Finanzdaten der Hookipa Pharma Inc-Aktie (HOOK)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$28.10
price down icon 2.90%
$47.47
price up icon 2.73%
$52.84
price down icon 1.35%
$107.48
price down icon 2.49%
$146.32
price down icon 2.02%
biotechnology ONC
$314.36
price down icon 0.83%
Kapitalisierung:     |  Volumen (24h):